363 related articles for article (PubMed ID: 20498311)
1. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
2. Pradimicin S, a highly soluble nonpeptidic small-size carbohydrate-binding antibiotic, is an anti-HIV drug lead for both microbicidal and systemic use.
Balzarini J; François KO; Van Laethem K; Hoorelbeke B; Renders M; Auwerx J; Liekens S; Oki T; Igarashi Y; Schols D
Antimicrob Agents Chemother; 2010 Apr; 54(4):1425-35. PubMed ID: 20047920
[TBL] [Abstract][Full Text] [Related]
3. Differences in the mannose oligomer specificities of the closely related lectins from Galanthus nivalis and Zea mays strongly determine their eventual anti-HIV activity.
Hoorelbeke B; Van Damme EJ; Rougé P; Schols D; Van Laethem K; Fouquaert E; Balzarini J
Retrovirology; 2011 Feb; 8(1):10. PubMed ID: 21314946
[TBL] [Abstract][Full Text] [Related]
4. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
[TBL] [Abstract][Full Text] [Related]
5. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
[TBL] [Abstract][Full Text] [Related]
6. Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.
Chiba H; Inokoshi J; Nakashima H; Omura S; Tanaka H
Biochem Biophys Res Commun; 2004 Mar; 316(1):203-10. PubMed ID: 15003531
[TBL] [Abstract][Full Text] [Related]
7. Microvirin, a novel alpha(1,2)-mannose-specific lectin isolated from Microcystis aeruginosa, has anti-HIV-1 activity comparable with that of cyanovirin-N but a much higher safety profile.
Huskens D; Férir G; Vermeire K; Kehr JC; Balzarini J; Dittmann E; Schols D
J Biol Chem; 2010 Aug; 285(32):24845-54. PubMed ID: 20507987
[TBL] [Abstract][Full Text] [Related]
8. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
[TBL] [Abstract][Full Text] [Related]
9. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.
Sanders RW; Venturi M; Schiffner L; Kalyanaraman R; Katinger H; Lloyd KO; Kwong PD; Moore JP
J Virol; 2002 Jul; 76(14):7293-305. PubMed ID: 12072528
[TBL] [Abstract][Full Text] [Related]
10. The high mannose-type glycan binding lectin actinohivin: dimerization greatly improves anti-HIV activity.
Takahashi A; Inokoshi J; Hachiya A; Oka S; Omura S; Tanaka H
J Antibiot (Tokyo); 2011 Aug; 64(8):551-7. PubMed ID: 21694730
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding.
Hong PW; Flummerfelt KB; de Parseval A; Gurney K; Elder JH; Lee B
J Virol; 2002 Dec; 76(24):12855-65. PubMed ID: 12438611
[TBL] [Abstract][Full Text] [Related]
12. Resistance of human immunodeficiency virus type 1 to the high-mannose binding agents cyanovirin N and concanavalin A.
Witvrouw M; Fikkert V; Hantson A; Pannecouque C; O'keefe BR; McMahon J; Stamatatos L; de Clercq E; Bolmstedt A
J Virol; 2005 Jun; 79(12):7777-84. PubMed ID: 15919930
[TBL] [Abstract][Full Text] [Related]
13. Role of the carbohydrate-binding sites of griffithsin in the prevention of DC-SIGN-mediated capture and transmission of HIV-1.
Hoorelbeke B; Xue J; LiWang PJ; Balzarini J
PLoS One; 2013; 8(5):e64132. PubMed ID: 23741304
[TBL] [Abstract][Full Text] [Related]
14. Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes.
Balzarini J; Van Laethem K; Peumans WJ; Van Damme EJ; Bolmstedt A; Gago F; Schols D
J Virol; 2006 Sep; 80(17):8411-21. PubMed ID: 16912292
[TBL] [Abstract][Full Text] [Related]
15. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus.
Balzarini J; Van Laethem K; Daelemans D; Hatse S; Bugatti A; Rusnati M; Igarashi Y; Oki T; Schols D
J Virol; 2007 Jan; 81(1):362-73. PubMed ID: 17050611
[TBL] [Abstract][Full Text] [Related]
16. Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.
Ghanem MH; Bolivar-Wagers S; Dey B; Hajduczki A; Vargas-Inchaustegui DA; Danielson DT; Bundoc V; Liu L; Berger EA
Cytotherapy; 2018 Mar; 20(3):407-419. PubMed ID: 29306566
[TBL] [Abstract][Full Text] [Related]
17. Broad anti-HIV activity of the Oscillatoria agardhii agglutinin homologue lectin family.
Férir G; Huskens D; Noppen S; Koharudin LM; Gronenborn AM; Schols D
J Antimicrob Chemother; 2014 Oct; 69(10):2746-58. PubMed ID: 24970741
[TBL] [Abstract][Full Text] [Related]
18. Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans.
Agrawal-Gamse C; Luallen RJ; Liu B; Fu H; Lee FH; Geng Y; Doms RW
J Virol; 2011 Jan; 85(1):470-80. PubMed ID: 20962094
[TBL] [Abstract][Full Text] [Related]
19. The phthalocyanine prototype derivative Alcian Blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potential.
François KO; Pannecouque C; Auwerx J; Lozano V; Pérez-Pérez MJ; Schols D; Balzarini J
Antimicrob Agents Chemother; 2009 Nov; 53(11):4852-9. PubMed ID: 19721061
[TBL] [Abstract][Full Text] [Related]
20. Mechanism by which the lectin actinohivin blocks HIV infection of target cells.
Tanaka H; Chiba H; Inokoshi J; Kuno A; Sugai T; Takahashi A; Ito Y; Tsunoda M; Suzuki K; Takénaka A; Sekiguchi T; Umeyama H; Hirabayashi J; Omura S
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15633-8. PubMed ID: 19717426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
